Literature DB >> 381583

Post-mortem distribution of dopamine and homovanillic acid in human brain, variations related to age, and a review of the literature.

R Adolfsson, C G Gottfries, B E Roos, B Winblad.   

Abstract

The post-mortem brain concentrations of dopamine (DA) and homovanillic acid (HVA) were determined in 16 parts of the brain from patients with no history of neurologic or psychiatric illness. Fifteen men and nine women, with a mean age of 61.0 +/- 18.7 years (range 23--92 years) were included. They had died from either ischaemic heart disease or cancer. In the post-mortem investigation several factors were controlled: age, time between death and autopsy, time between autopsy and chemical analysis and storage time (-20 degrees C). The DA concentrations in the different brain areas were found to be positively intercorrelated, especially those in the basal ganglia, hippocampus and the mesencephalon. The HVA concentrations measured in various cortical structures were also positively intercorrelated. In several regions of the brain there was a significant inverse correlation between the DA and HVA concentrations. The DA and HVA concentrations did not differ according to sex, but age had a marked influence on the DA concentration. Significant decrease with age was observed in the nucleus caudatus, globus pallidus, mesencephalon, hippocampus and in the cortex gyrus hippocampus. These findings are discussed in relation to the effect of aging neurons. A review of human post-mortem investigations on DA and HVA concentrations is also presented.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 381583     DOI: 10.1007/bf01250085

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  65 in total

1.  On the occurrence of homovanillic acid in brain and cerebrospinal fluid and its determination by a fluorometric method.

Authors:  N E ANDEN; B E ROOS; B WERDINIUS
Journal:  Life Sci (1962)       Date:  1963-07

2.  Organization of the cerebral cortex. III. A study of aging in the human cerebral cortex.

Authors:  H BRODY
Journal:  J Comp Neurol       Date:  1955-04       Impact factor: 3.215

3.  Enzymes associated with the metabolism of catecholamines, acetylcholine and gaba in human controls and patients with Parkinson's disease and Huntington's chorea.

Authors:  P L McGeer; E G McGeer
Journal:  J Neurochem       Date:  1976-01       Impact factor: 5.372

Review 4.  Biochemistry of catecholamines.

Authors:  P B Molinoff; J Axelrod
Journal:  Annu Rev Biochem       Date:  1971       Impact factor: 23.643

Review 5.  Basic actions of psychoactive drugs.

Authors:  A Carlsson
Journal:  Int J Neurol       Date:  1967

6.  Huntington's chorea: pathology and brain amines.

Authors:  B Mattsson; C G Gottfries; B E Roos; B Winblad
Journal:  Acta Psychiatr Scand Suppl       Date:  1974

7.  Monoamines in the human neostriatum: topographic distribution in normals and in Parkinson's disease and their role in akinesia, rigidity, chorea, and tremor.

Authors:  S Fahn; L R Libsch; R W Cutler
Journal:  J Neurol Sci       Date:  1971-12       Impact factor: 3.181

8.  [Attempted localization of monoamines in human hypothalamus].

Authors:  J Constantinidis; R Tissot; J C De la Torre; F Geissbuhler
Journal:  Pathol Biol (Paris)       Date:  1969-04

9.  Activities of enzymes involved in the formation and destruction of biogenic amines in various areas of human brain.

Authors:  W H Vogel; V Orfei; B Century
Journal:  J Pharmacol Exp Ther       Date:  1969-02       Impact factor: 4.030

10.  Huntington's chorea. Post-mortem measurement of glutamic acid decarboxylase, choline acetyltransferase and dopamine in basal ganglia.

Authors:  E D Bird; L L Iversen
Journal:  Brain       Date:  1974-09       Impact factor: 13.501

View more
  36 in total

1.  A within-subject comparison of 6-[18F]fluoro-m-tyrosine and 6-[18F]fluoro-L-dopa in Parkinson's disease.

Authors:  Catherine L Gallagher; Bradley T Christian; James E Holden; Onofre T Dejesus; Robert J Nickles; Laura Buyan-Dent; Barbara B Bendlin; Sandra J Harding; Charles K Stone; Barb Mueller; Sterling C Johnson
Journal:  Mov Disord       Date:  2011-06-02       Impact factor: 10.338

2.  Effect of aging on lazabemide binding, monoamine oxidase activity and monoamine metabolites in human frontal cortex.

Authors:  M D Galva; G P Bondiolotti; M Olasmaa; G B Picotti
Journal:  J Neural Transm Gen Sect       Date:  1995

3.  Elevated 5-S-cysteinyldopamine/homovanillic acid ratio and reduced homovanillic acid in cerebrospinal fluid: possible markers for and potential insights into the pathoetiology of Parkinson's disease.

Authors:  F C Cheng; J S Kuo; L G Chia; G Dryhurst
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

4.  Aged monkeys as a partial model for Parkinson's disease.

Authors:  P J Hurley; J D Elsworth; M C Whittaker; R H Roth; D E Redmond
Journal:  Pharmacol Biochem Behav       Date:  2011-05-18       Impact factor: 3.533

5.  Autoradiographic localization of dopamine D 1 and D 2 receptors in the brain of several mammalian species.

Authors:  M Camps; P H Kelly; J M Palacios
Journal:  J Neural Transm Gen Sect       Date:  1990

Review 6.  Depression in the elderly: the role of the primary care physician in management.

Authors:  J F McGreevey; K Franco
Journal:  J Gen Intern Med       Date:  1988 Sep-Oct       Impact factor: 5.128

7.  Dopamine metabolism increases in post-mortem schizophrenic basal ganglia.

Authors:  M Toru; T Nishikawa; N Mataga; M Takashima
Journal:  J Neural Transm       Date:  1982       Impact factor: 3.575

8.  The effect of age on the activity and molecular properties of human brain monoamine oxidase.

Authors:  C J Fowler; A Wiberg; L Oreland; J Marcusson; B Winblad
Journal:  J Neural Transm       Date:  1980       Impact factor: 3.575

9.  Effect of a reversible and selective MAO-A inhibitor (cimoxatone) on diurnal variation in plasma prolactin level in man.

Authors:  M Strolin Benedetti; A Eschalier; A Lesage; G Dordain; V Rovei; E Zarifian; P Dostert
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

10.  Reduced concentrations and increased metabolism of biogenic amines in a single case of Rett-syndrome: a postmortem brain study.

Authors:  T Brücke; E Sofic; W Killian; A Rett; P Riederer
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.